TScan Therapeutics Inc. (TCRX)

AI Score

Unlock

1.72

0.09 (5.52%)

At close: Apr 24, 2025, 3:59 PM

1.66

-3.49%

After-hours: Apr 24, 2025, 07:42 PM EDT

TScan Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-127.5M	-111.3M	-104.41M	-96.8M	-89.22M	-88.33M	-81.58M	-72.63M	-66.22M	-61.7M	-61.29M	-56.87M	-48.63M	-42.23M	-33.56M	-28.5M	-26.13M	-18.32M	-11.15M	-5.54M
Depreciation & Amortization	4.11M	4.68M	4.94M	5.12M	5.36M	5.57M	5.53M	5.44M	5.14M	4.79M	4.6M	4.05M	3.33M	2.58M	1.87M	1.48M	1.23M	834K	488K	222K
Stock-Based Compensation	9.55M	8.34M	7.15M	6.04M	5.21M	5M	4.91M	4.71M	4.55M	4.04M	3.68M	3.16M	2.52M	1.88M	1.13M	748K	515K	365K	236K	111K
Other Working Capital	3.06M	-6.77M	23.2M	20.34M	17.66M	22.52M	-8.43M	-8.26M	-10.85M	-9.8M	-8.14M	-9.86M	-5.91M	-6.41M	-5.45M	17.6M	20.23M	20.38M	20.04M	-394K
Other Non-Cash Items	2.87M	7.12M	8.65M	9.05M	4.62M	871K	-2.66M	148K	2.48M	-3.63M	1.8M	-834K	-2.26M	3.63M	1.89M	21.53M	20.88M	20.88M	20.5M	469K
Deferred Income Tax	n/a	-4.7M	-4.94M	-4.94M	-4.94M	-235K	n/a	n/a	n/a	5.9M	5.9M	5.9M	5.9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	5.05M	-6.4M	22.27M	19.38M	17.61M	23.52M	-8.18M	-7.97M	-10.23M	-12.05M	-8.5M	-9.19M	-5.9M	-3.88M	-3.23M	18.42M	21.36M	21.45M	20.54M	75K
Operating Cash Flow	-110.82M	-107.18M	-71.24M	-67.04M	-61.36M	-53.6M	-78.62M	-69.97M	-66.5M	-64.87M	-61.51M	-58.84M	-48.68M	-41.65M	-33.8M	-7.85M	-3.02M	4.33M	10.12M	-5.13M
Capital Expenditures	-3.83M	-3.41M	-3.46M	-3.01M	-3.15M	-4.05M	-3.06M	-4.53M	-4.22M	-5.06M	-5.49M	-7.51M	-9.94M	-9.12M	-9.61M	-6.01M	-4.24M	-2.85M	-1.51M	-1.19M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-241.44M	-211.73M	-134.75M	-86.39M	-77.61M	-59.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	192.66M	137.15M	81.15M	65.65M	20M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	36.87M	39.25M	-20.75M	-20.75M	-57.61M	-59.99M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-52.61M	-77.99M	-57.05M	-23.76M	-60.76M	-64.05M	-3.06M	-4.53M	-4.22M	-5.06M	-5.49M	-7.51M	-9.94M	-9.12M	-9.61M	-6.01M	-4.24M	-2.85M	-1.51M	-1.19M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	176K	176K	176K	176K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	208.76M	163.09M	161.8M	135.89M	135.63M	135.72M	164.91M	29.27M	29.36M	29.37M	90.85M	90.13M	89.94M	89.86M	-749K	-37K	288K	248K	247K	221K
Financial Cash Flow	208.76M	163.09M	161.61M	135.7M	135.44M	135.53M	164.91M	29.27M	29.36M	29.37M	90.85M	90.13M	189.67M	189.59M	98.98M	99.69M	288K	248K	247K	221K
Net Cash Flow	45.33M	-22.07M	33.32M	44.91M	13.33M	17.88M	83.23M	-45.23M	-41.37M	-40.56M	23.85M	23.77M	131.05M	138.83M	55.58M	85.83M	-6.97M	1.72M	8.85M	-6.09M
Free Cash Flow	-114.65M	-110.58M	-74.7M	-70.05M	-64.5M	-57.66M	-81.68M	-74.5M	-70.73M	-69.93M	-67M	-66.36M	-58.62M	-50.76M	-43.4M	-13.86M	-7.26M	1.47M	8.61M	-6.32M